Central actions of agmatine in conscious spontaneously hypertensive rats

Clinical and Experimental Hypertension

Volumn 27, Issue 8, 2005, Pages 619-627

  Briaud, S ^a   Zhang, B ^a   Sannajust, F ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

Agmatine; Cisterna magna; Clonidine displacing substance; Heart rate; Spontaneously hypertensive rats

Indexed keywords

AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; CLONIDINE; IMIDAZOLINE; RILMENIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; BRAIN FOURTH VENTRICLE; CARDIOVASCULAR FUNCTION; CISTERNA MAGNA; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; ESSENTIAL HYPERTENSION; HEART RATE; LOW DRUG DOSE; MALE; NONHUMAN; RAT; RECEPTOR AFFINITY; SPONTANEOUSLY HYPERTENSIVE RAT;

AGMATINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN; CARDIOVASCULAR SYSTEM; CLONIDINE; CONSCIOUSNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HEART RATE; HYPERTENSION; INJECTIONS, INTRAVENTRICULAR; MALE; MOVEMENT; OXAZOLES; RATS; RATS, INBRED SHR;

EID: 28444464800     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960500298632     Document Type: Article

References (23)

1. Schmitt H. The pharmacology of clonidine and related products. In: Handbook of Experimental Pharmacology. Vol. 39. Berlin: Springer-Verlag, 1997:1-299.
2. Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha-2 adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 1984; 230:232-236.
3. Li G, Regunathan S, Barrow C, Eshragi J, Cooper R, Reis D. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994; 263(5149):966-969.
4. Regunathan S, Feinstein DL, Raasch W, Reis DJ. Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes. NeuroReport 1995; 6(14):1897-1900.
5. Otake K, Ruggiero DA, Regunathan S, Wang H, Milner TA, Reis DJ. Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res 1998; 787(1):1-14.
6. Sun M, Regunathan S, Reis D. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat. Clin Exp Hypertens 1995; 17(1&2):115-128.
7. Schafer U, Raasch W, Qadri F, Chun J, Dominiak P. Effects of agmatine on the cardiovascular system of spontaneously hypertensive rats. Ann NY Acad Sci 1999; 881:97-101.
8. Raasch W, Schafer U, Qadri F, Dominiak P. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Br J Pharmacol 2002; 135:663-672.
9. Szabo B, Urban R, Limberger N, Starke K. Cardiovascular effects of agmatine, a clonidine-displacing substance in conscious rabbits. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 351:10-16.
10. Head G, Chan C, Godwin S. Central cardiovascular actions of agmatine, a putative clonidine-displacing substance, in conscious rabbits. Neurochem Int 1997; 30(1):37-45.
11. Howes LG, Rowe PR, Summers RJ, Louis WJ. Age related changes of catecholamines and their metabolites in central nervous system regions of spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats. Clin Exp Hypertens, A 1984; 6(12):2263-2277.
12. Sannajust F, Cerruti C, Koenig-Berard E, Sassard J. Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats. Br J Pharmacol 1992; 105(3):542-548.
13. Head GA, Korner PL, Lewis SL, Badoer E. Contribution of noradrenergic and serotoninergic neurons to the circulatory effects of centrally acting clonidine and α-methyldopa in rabbits. J Cardiovasc Pharmacol 1983; 5:945-953.
14. Reja V, Goodchild A, Pilowsky P. Catecholamine-related gene expression correlates with blood pressure in SHR. Hypertension 2002; 40(3):342-347.
15. Head G, Godwin S, Sannjust F. Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits. J Hypertens 1993; 11(suppl 5):S322-S323.
16. Sannajust F, Head G. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone. Am J Cardiol 1994 Dec 22; 74(13):7A-19A.
17. Head G, Burke SL, Sannajust FJ. Involvement of imidazoline receptors in the baroreflex effects of rilmenidine in conscious rabbits. J Hypertens 2001; 19(9):1615-1624.
18. Ohashi K, Nishikawa K, Hatano M, Mori T, Asada A. Dose-related attenuation of cardiac sympathetic nerve activity and intracardiac conduction with thoracic epidural clonidine in alpha-chloralose-anesthetized cats. Osaka City Med J 2002; 48(1):45-58.
19. Olmos G, DeGregorio-Rocasolano N, Paz Regalo M, Gasull T, Assumpcio Boronat M, Trullas R, Villarroel A, Lerma J, Garcia-Sevilla JA. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol 1999; 127(6):1317-1326.
20. Bence A, Worthen D, Stables J, Crooks P. An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine. Pharmacol Biochem Behav 2003; 74:771-775.
21. Su RB, Wei XL, Zheng JQ, Liu Y, Lu XQ, Li J. Anticonvulsive effects of agmatine in mice. Pharmacol Biochem Behav 2004; 77:345-349.
22. Demehri S, Homayoun H, Honar H, Riazi K, Vafaie K, Roushanzamir F, Dehpour A. Agmatine exerts anticonvulsant effect in mice: modulation by alpha-2 adrenoceptors and nitric oxide. Neuropharmacology 2003; 45:534-542.
23. Abe K, Abe Y, Saito H. Agmatine induces glutamate release and cell death in cultured rat cerebellar granule neurons. Brain Res 2003; 990(1-2):165-171.